FHA
MED icon

Flagship Harbor Advisors’s Medifast MED Stock Holding History

Flagship Harbor Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18
Closed -$2K – 1241
2020
Q3 		$2K Buy
18
+16
+800% +$2.63K ﹤0.01% 1738
2020
Q2 		$0 Hold
2
– – ﹤0.01% 2101
2020
Q1 		$0 Hold
2
– – ﹤0.01% 1918
2019
Q4 		$0 Sell
2
-51
-96% -$4.94K ﹤0.01% 1923
2019
Q3 		$5K Sell
53
-52
-50% -$5.59K ﹤0.01% 1495
2019
Q2 		$13K Sell
105
-38
-27% -$5.28K ﹤0.01% 1214
2019
Q1 		$18K Buy
143
+1
+0.7% +$127 ﹤0.01% 1118
2018
Q4 		$17K Sell
142
-11
-7% -$1.88K ﹤0.01% 1071
2018
Q3 		$34K Buy
153
+120
+364% +$24.3K 0.01% 943
2018
Q2 		$5K Buy
+33
New +$4.22K ﹤0.01% 1650

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Flagship Harbor Advisors's MED Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Medifast (MED) in Q4 2020, closing a stake of 18 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in MED in Q2 2018 and held it in 10 quarters. The position peaked at $34K in Q3 2018. 261 funds tracked by Wall St. Rank hold MED as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Medifast position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 18 Medifast shares in Q4 2020, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Medifast in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Medifast position peaked at $34K in Q3 2018.
  • 261 funds tracked by Wall St. Rank held Medifast as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.